SNDRIScottish Nutrition and Diet Resources Initiative
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Liafensine (DB104) is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI), a late-stage CNS drug.
Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.
SEP-225289 - Sepracor has completed a Phase I, single-blind, randomized, placebo-controlled safety, tolerability and pharmacokinetic clinical study for SEP-225289, a serotonin, norepinephrine and dopamine reuptake inhibitor (SNDRI), for the treatment of major depressive disorder and plans to initiate a multiple dose pharmacokinetic study during the third quarter of 2006.